News and Events

HaploX, a leading precision medicine company, is pleased to announce its participation in the upcoming Macao Greater Health Medical Development Summit Forum 2025. Dr. Yingxiang Li from HaploX is scheduled to deliver a featured speech at this prestigious event, which will be held on November 30, 2025, in Macao.

Organized by the Macao Greater Health Medical Development Association, this high-level international forum will bring together globally renowned medical experts, researchers, industry leaders, and policymakers. The event is designed to foster dialogue on cutting-edge trends, innovative technologies, and industrial opportunities within the greater health sector, promoting in-depth integration across industry, academia, research, and clinical practice.

Dr. Li’s presentation, titled “Precision in Practice: Leveraging Genomic Testing for Superior Diagnosis and Treatment,” will explore the vital role of genomic technologies in shaping the future of healthcare. He will share insights on translating genomic data into clinical applications to enhance diagnostic precision, optimize treatment strategies, and improve patient outcomes. The session will also highlight HaploX’s ongoing efforts to make advanced genomic testing more accessible and actionable in real-world medical settings. “We are excited to contribute to this influential forum and support Macao’s vision of becoming a health city benchmark in the Greater Bay Area and internationally,” said a representative from HaploX. “Dr. Li’s presentation reflects our commitment to bridging genomic innovation with everyday clinical practice.”

The Macao Greater Health Medical Development Summit Forum 2025 is set to serve as a key platform for sharing knowledge and strategies to advance Macao’s integrated health system, spanning prevention, treatment, rehabilitation, and wellness.